Sonidegib tolerability across 30-months: Results from the phase 2 randomized BOLT trial

被引:0
|
作者
Stockfleth, E. [1 ]
机构
[1] Univ Hautklin Bochum, St Josef Hosp, Bochum, Germany
关键词
D O I
10.1016/j.jid.2017.07.739
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
542
引用
收藏
页码:S285 / S285
页数:1
相关论文
共 50 条
  • [41] Antineoplastic therapy after discontinuation of sonidegib 200 mg in patients with advanced basal cell carcinoma: Results from the 42-month, randomized, double-blind BOLT study
    Gutzmer, Ralf
    Guminski, Alexander
    Foley, Peter
    Chang, Anne Lynn S.
    Lewis, Karl
    Squittieri, Nicholas
    Loquai, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB89 - AB89
  • [42] Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
    Bradley, John S.
    Roilides, Emmanuel
    Btvadhurst, Helen
    Cheng, Karen
    Huang, Li-Min
    MasCasullo, Veronica
    Newell, Paul
    Stone, Gregory G.
    Mwadrous, Margaret
    Wajsbn, Dalia
    Yates, Katrina
    Gardner, Annie
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (09) : 920 - 928
  • [43] Intracerebral administration of rAAV2/5hNAGLU vector in children with MPS IIIB: results at 30 months of a phase I/II trial
    Tardieu, Marc
    Zerah, Michel
    Gougeon, Marie-Lise
    Ausseil, Jerome
    de Bournonville, Stephanie
    Husson, Beatrice
    Zafeiriou, Dimitrios
    Parenti, GianCarlo
    Bourget, Philippe
    Artaud, Cecile
    Poirier, Beatrice
    VanVlies, Noami
    Deiva, Kumaran
    Baugnon, Thomas
    Roujeau, Thomas
    Crystal, Ronald G.
    Richard, Charles
    Heard, Jean-Michel
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S130 - S130
  • [44] Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial
    Taylor, Hugh S.
    Dong, Liying
    Haikonen, Johanna
    Oppelt, Peter
    Tamussino, Karl
    Wenzl, Rene
    Faustmann, Thomas
    Groettrup-Wolfers, Esther
    Ren, Xiaowei
    Seitz, Christian
    F&S REPORTS, 2024, 5 (02): : 189 - 196
  • [45] COMPARING COMPOSITE MEASURES OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL WITH GUSELKUMAB
    Helliwell, Philip
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Xu, Xie L.
    Xu, Stephen
    Wang, Yuhua
    Hsia, Elizabeth C.
    Gladman, Dafna D.
    Ritchlin, Christopher T.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1843 - 1843
  • [46] Cicletanine in pulmonary arterial hypertension (PAH): Results from a phase 2 randomized placebo-controlled trial
    Waxman, Aaron
    Oudiz, Ronald
    Shapiro, Shelley
    Gomberg-Maitland, Mardi
    Keogh, Anne
    Badesch, David
    Frantz, Robert
    Elliott, C. Gregory
    Gillies, Hunter
    Walker, Gennyne
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [47] A 12-month update of BOLT, a phase 2, randomized, double-blind study of sonidegib (LDE225) in patients with locally advanced or metastatic basal cell carcinoma
    Migden, M. R.
    Gutzmer, R.
    Guminski, A.
    Yi, T.
    Gogov, S.
    Lear, J.
    Dummer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (08) : S6 - S6
  • [48] A 12-month update of BOLT, a phase 2, randomized, double-blind study of sonidegib (LDE225) in patients with locally advanced or metastatic basal cell carcinoma
    Migden, Michael
    Gutzmer, Ralf
    Guminski, Alexander
    Yi, Tingting
    Gogov, Sven
    Lear, John
    Dummer, Reinhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB178 - AB178
  • [49] Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women A Phase 2 Randomized Trial
    Gulick, Roy M.
    Wilkin, Timothy J.
    Chen, Ying Q.
    Landovitz, Raphael J.
    Amico, K. Rivet
    Young, Alicia M.
    Richardson, Paul
    Marzinke, Mark A.
    Hendrix, Craig W.
    Eshleman, Susan H.
    McGowan, Ian
    Cottle, Leslie M.
    Andrade, Adriana
    Marcus, Cheryl
    Klingman, Karin L.
    Chege, Wairimu
    Rinehart, Alex R.
    Rooney, James F.
    Andrew, Philip
    Salata, Robert A.
    Siegel, Marc
    Manabe, Yukari C.
    Frank, Ian
    Ho, Ken
    Santana, Jorge
    Stekler, Joanne D.
    Swaminathan, Shobha
    McCauley, Marybeth
    Hodder, Sally
    Mayer, Kenneth H.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (06) : 384 - +
  • [50] A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
    Cutolo, Maurizio
    Myerson, Gary E.
    Fleischmann, Roy M.
    Liote, Frederic
    Diaz-Gonzalez, Federico
    Van den Bosch, Filip
    Marzo-Ortega, Helena
    Feist, Eugen
    Shah, Kamal
    Hu, ChiaChi
    Stevens, Randall M.
    Poder, Airi
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1724 - 1734